Ibogaine Treatment for Parkinson’s Disease
More than 55 million people globally suffer from neurodegenerative illnesses, including Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease, with such conditions sadly being on the rise. Parkinson’s disease is the second most prevalent neurodegenerative disorder after Alzheimer’s and results from the loss of specific brain cells that produce dopamine in the mid-brain. This loss leads …